Form D · Other
Evommune, Inc.
Palo Alto, CA · CIK 0002044725
Offering snapshot reported Jan 8, 2025 · SEC filing
- Reported sold
- $57.5M Offering amount: $57.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2025 | Initial | $57,500,000 | No comparison | 16 | SEC filing |
| Jan 8, 2025 | Initial | $81,799,952 | No comparison | 10 | SEC filing |
| Jan 8, 2025 | Initial | $115,499,956 | No comparison | 25 | SEC filing |
| Jan 7, 2025 | Initial | $12,462,474 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-534516
Source: Form D, filed Jan 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eugene Bauer | Director, Executive |
| Francois Beaubien | Director |
| Kyle Carver | Executive |
| David Cohen | Director |
| Derek Di Rocco | Director |
| Janice Drew | Executive |
| Robert Hopfner | Director |
| Benjamin Mc Graw | Director |
| Gregory Moss | Executive |
| Jeegar Patel | Executive |
| Luis Pena | Director, Executive |
| Felice Verduyn Van Weegen | Director |
| Yuexin Yu | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1841 Page Mill Rd
Palo Alto, CA, 94304
Palo Alto, CA, 94304